Relmada Therapeutics, Inc.(RLMD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RLMD Relmada Therapeutics, Inc.

未开盘 05-20 16:00:00 EDT

3.24

-0.10

-2.99%

盘后3.24

+0.000.00%

17:51 EDT

最高3.44	最低3.24	成交量6.34万
今开3.36	昨收3.34	日振幅5.99%
总市值9,776万	流通市值8,991万	总股本3,017万
成交额20.93万	换手率0.23%	流通股本2,775万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RLMD","market":"US","secType":"STK","nameCN":"Relmada Therapeutics, Inc.","latestPrice":3.24,"timestamp":1716235200000,"preClose":3.34,"halted":0,"volume":63353,"hourTrading":{"tag":"盘后","latestPrice":3.24,"preClose":3.24,"latestTime":"17:51 EDT","volume":41,"amount":132.59,"timestamp":1716241861020},"delay":0,"floatShares":27749203,"shares":30174202,"eps":-3.132135,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.1,"latestTime":"05-20 16:00:00 EDT","open":3.36,"high":3.44,"low":3.24,"amount":209270.6832146,"amplitude":0.05988,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.132135,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716278400000},"adr":0,"adjPreClose":3.34,"preHourTrading":{"tag":"盘前","latestPrice":3.36,"preClose":3.34,"latestTime":"09:28 EDT","volume":800,"amount":2688,"timestamp":1716211680010},"postHourTrading":{"tag":"盘后","latestPrice":3.24,"preClose":3.24,"latestTime":"17:51 EDT","volume":41,"amount":132.59,"timestamp":1716241861020},"volumeRatio":1.001337},"requestUrl":"/m/hq/s/RLMD","defaultTab":"news","newsList":[{"id":"2420798966","title":"美国研究综述-迪克体育用品、Nvidia、PVH","url":"https://stock-news.laohu8.com/highlight/detail?id=2420798966","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2420798966?lang=zh_cn&edition=full","pubTime":"2024-03-20 15:14","pubTimestamp":1710918896,"startTime":"0","endTime":"0","summary":"    路透社3月20日 - 华尔街证券分析师周三调整了对迪克体育用品公司、英伟达和 PVH 等几家美国上市公司的评级和目标价。股票条目按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.relmada.com","stockEarnings":[{"period":"1week","weight":-0.0538},{"period":"1month","weight":-0.2863},{"period":"3month","weight":-0.4025},{"period":"6month","weight":0.1929},{"period":"1year","weight":0.074},{"period":"ytd","weight":-0.1932}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Relmada Therapeutics, Inc.是私人控股公司，于2004年5月注册成立。该公司是一家临床阶段的生物制药公司，致力于开发用于治疗慢性疼痛的候选药物。该公司专注于开发d-methadone（右美沙酮，REL-1017），一种N-甲基-D-天冬氨酸（NMDA）受体拮抗剂。美沙酮是一种新的化学实体，可能解决中枢神经系统（CNS）疾病和其他疾病治疗中未满足医疗需求的领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.047507},{"month":2,"riseRate":0.666667,"avgChangeRate":0.107392},{"month":3,"riseRate":0.5,"avgChangeRate":-0.035153},{"month":4,"riseRate":0.666667,"avgChangeRate":0.029344},{"month":5,"riseRate":0.428571,"avgChangeRate":0.022634},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.131715},{"month":7,"riseRate":0.666667,"avgChangeRate":0.068701},{"month":8,"riseRate":0.5,"avgChangeRate":0.03989},{"month":9,"riseRate":0.833333,"avgChangeRate":0.09509},{"month":10,"riseRate":0.333333,"avgChangeRate":0.10844},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.069992},{"month":12,"riseRate":0.5,"avgChangeRate":0.132279}],"exchange":"NASDAQ","name":"Relmada Therapeutics, Inc.","nameEN":"Relmada Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Relmada Therapeutics, Inc.(RLMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Relmada Therapeutics, Inc.(RLMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Relmada Therapeutics, Inc.,RLMD,Relmada Therapeutics, Inc.股票,Relmada Therapeutics, Inc.股票老虎,Relmada Therapeutics, Inc.股票老虎国际,Relmada Therapeutics, Inc.行情,Relmada Therapeutics, Inc.股票行情,Relmada Therapeutics, Inc.股价,Relmada Therapeutics, Inc.股市,Relmada Therapeutics, Inc.股票价格,Relmada Therapeutics, Inc.股票交易,Relmada Therapeutics, Inc.股票购买,Relmada Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Relmada Therapeutics, Inc.(RLMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Relmada Therapeutics, Inc.(RLMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}